PharmaTelevision - BioServe: One of the Largest Commercial Biobanks in the World

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: BioServe: One of the Largest Commercial Biobanks in the World

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks to Rob Fannon, Clinical Operations Manager at BioServe. They discuss:

• BioServe 's Origins and focus

• Biobanks,sample tissue data and focussed therapy areas

• BioServe network and relationship with Institutions

• BioServe 's positioning strategy with clients

• Recent acqusitions and future model of growth

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

BioServe 's Origins and focus

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here at BioPharm America in Boston. On this show I have Rob Fannon, who is Clinical Operations Manager at a company called BioServe based in Maryland, welcome to the show.

Rob Fannon:

Thank you very much, thanks for having me.

Fintan Walton:

Rob Fannon, could you tell us about BioServe , because you're an interesting company focused in preclinical research, tell us little bit more about BioServe ?

Rob Fannon:

Sure, if you had to characterize our company work closes to a preclinical CRO. The crux of our business really focuses on one of the largest commercial biobanks in the world. At present in-house we have about 600,000 samples these are tissue, RNA, blood, blood related products that was collected over from over a 100,000 patients, each one of these samples is associated with about 200 data fields, standard demographic data, disease specific data, so this really drives the value of our company today, our business model if you had to characterize it would be sort of a sample to data model where we'll engage our clients and everything from simple sample transactions to a little bit more of a long-term relationship where we'll keep those samples in-house perform some of the standard molecular services associated with that may be DNA, RNA extraction. We can do some genotyping work, sequencing, gene expression studies where we'll actually deliver data to our clients, so it's a really nice fit and that was sort of the historical back drop of our company that's service based organization.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

Rob Fannon

Clinical Operations Manager

Rob Fannon , Clinical Operations Manager, BioServe

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

BioServe

BioServe is a private company categorized under Biological Laboratories and located in Beltsville, MaryLand. BioServe 's 'biomaterial to data' model offers one of the world's largest commercial biorepositories and a full suite of preclinical molecular services and research tools to accelerate breakthroughs in genetics, drug discovery, biomarker research, and molecular diagnostics. BioServe 's Global BioRepository provides leading academic and industry researchers with access to over 600,000 human DNA, tissue and serum samples linked to detailed clinical and demographic data from 120,000 consented and anonymized patients on four continents. Utilizing BioServe 's preclinical molecular services, researchers can identify genetic markers, validate drug targets and correlate clinical and molecular data to accelerate the development of new and safer drugs. BioServe 's research tools division offers everything from nucleic acids processing, DNA synthesis, high throughput sequencing and genotyping, genome wide-scans and gene expression analysis to ready-made large epidemiologically sound case-control studies. BioServe 's customers include nearly every major pharmaceutical and biotechnology company, as well as top industry, academic, and government research institutions. Founded in 1989, BioServe has corporate headquarters in Beltsville, Maryland and Hyderabad, India.